Saptalis Drug Patent Portfolio
Saptalis owns 1 orange book drug protected by 2 US patents Given below is the list of Saptalis's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11541035 | Oral formulations of metronidazole and methods of treating an infection using same | 04 Oct, 2039 | Active |
| US12257236 | Oral formulations of metronidazole and methods of treating an infection using same | 16 Jan, 2039 | Active |
Latest Legal Activities on Saptalis's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Saptalis.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification | 25 Mar, 2025 | US12257236 |
| Recordation of Patent Grant Mailed | 25 Mar, 2025 | US12257236 |
| Recordation of Patent eGrant | 25 Mar, 2025 | US12257236 |
| Patent eGrant Notification | 25 Mar, 2025 | US12257236 |
| Mail Patent eGrant Notification | 25 Mar, 2025 | US12257236 |
| Patent Issue Date Used in PTA Calculation | 25 Mar, 2025 | US12257236 |
| Issue Notification Mailed | 05 Mar, 2025 | US12257236 |
| Email Notification | 05 Mar, 2025 | US12257236 |
| Application Is Considered Ready for Issue | 24 Feb, 2025 | US12257236 |
| Dispatch to FDC | 24 Feb, 2025 | US12257236 |
| Issue Fee Payment Verified | 21 Feb, 2025 | US12257236 |
| Issue Fee Payment Received | 21 Feb, 2025 | US12257236 |
| Change in Power of Attorney (May Include Associate POA) | 23 Dec, 2024 | US12257236 |
| Email Notification | 23 Dec, 2024 | US12257236 |
| Mail Notice of Allowance | 21 Nov, 2024 | US12257236 |
Saptalis's Family Patents
Saptalis Drug List
Given below is the complete list of Saptalis's drugs and the patents protecting them.
1. Likmez
Likmez is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11541035 | Oral formulations of metronidazole and methods of treating an infection using same |
04 Oct, 2039
(13 years from now)
| Active |
| US12257236 | Oral formulations of metronidazole and methods of treating an infection using same |
16 Jan, 2039
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Likmez's drug page